Chile vs Republic of Moldova: The number of people with susceptibility test result for rifampicin
Chile
96.15
in 2021
Republic of Moldova
96.4
in 2021
Chile rank
46th
Republic of Moldova rank
44th
The number of people with susceptibility test result for rifampicin over time
- Chile
- Republic of Moldova
How they compare
Republic of Moldova currently reports 96.4 against 96.15 in Chile, a difference of 0.25.
Across all 5 years both countries report, Republic of Moldova has been ahead every year.
Chile ranks 46th and Republic of Moldova ranks 44th of 146 countries.
Republic of Moldova has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 85.78 | 96.53 | 10.76 | Republic of Moldova |
| 2020s | 93.72 | 95.87 | 2.15 | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chile or Republic of Moldova?
- Republic of Moldova, at 96.4 against 96.15 in Chile as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chile and Republic of Moldova?
- 0.25, with Republic of Moldova ahead.
- How many years of comparable data are there for Chile and Republic of Moldova?
- 5 years are reported by both, from 2017 to 2021.
- How do Chile and Republic of Moldova rank globally for the number of people with susceptibility test result for rifampicin?
- Chile ranks 46th and Republic of Moldova ranks 44th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.